BDBM286136 4-(4-(2-methoxy- 5-(trifluorometh- oxy)benzyloxy) bicyclo[2.2.1] heptan-1-yl) butanoic acid::US9518000, Example 29::US9518000, Example 30

SMILES OC(=O)CCCC12CCC(CC1)(C2)OCc1csc2ccc(Cl)cc12

InChI Key InChIKey=BHKBJIFSZCSGDV-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 286136   

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286136(4-(4-(2-methoxy- 5-(trifluorometh- oxy)benzyloxy) ...)
Affinity DataEC50:  850nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent

TargetFree fatty acid receptor 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286136(4-(4-(2-methoxy- 5-(trifluorometh- oxy)benzyloxy) ...)
Affinity DataEC50:  5.07E+3nMT: 2°CAssay Description:The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/14/2019
Entry Details
US Patent